Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer
Age: Adult
Dose: Oral – 90 mg
Frequency: once daily
Duration: first 7 days
Note: As detected by an FDA-approved test.
Indication: Anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer
Age: Adult
Dose: Oral – 180 mg
Frequency: once daily
Note: Increase to this dose after the first 7 days. Continue until disease progression or unacceptable toxicity. As detected by an FDA-approved test.

Child Dose

Clinical InformationAdministration Information
Age: Pediatric
Dose: Tablet – No approved pediatric dosage available
Note: Not recommended

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment Mild or moderate (Creatinine Clearance 30-89 mL/min)
Dose: Tablet – Dosage not specified
Note: No dose adjustment required
Condition: Renal impairment Severe (Creatinine Clearance 15-29 mL/min)
Dose: Tablet – Reduce brigatinib dose by approximately 50% (example: from 180 mg to 90 mg, or from 90 mg to 60 mg)
Note: Dosage reduction required for severe renal impairment
Administration
  • Take with or without food
  • Take at same time each day
Side Effect

Drug Interaction

Drug NameRisk Factors
Boceprevir, cobicistat, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, clarithromycin, itraconazole, ketoconazole, posaconazole, voriconazole, grapefruit juice
Increased plasma concentration and adverse reactions
Rifampin, carbamazepine, phenytoin, St. John's Wort
Decreased plasma concentration and efficacy

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.